Our findings are also consistent with the observation of increased expression of Gal-1 in aggressive and metastatic oligodendroglioma [51], aggressive B16 melanoma [44], and Kaposi’s sarcoma [43]. This evidence concerns the gene LGALS1 and Kaposi's sarcoma.